Intravenous administration of RNA suppresses the induction of delayed-type hypersensitivity (DTH) to tumor-associated antigens. Academic Article
Overview
publication date
- August 1, 2000
published in
Identity
Digital Object Identifier (DOI)
- 10.1046/j.1523-1747.2000.00abs-9.x
PubMed ID
- 10951265
Additional Document Info
volume
- 115
issue
- 2